Bills to curb pharmaceutical companies' anticompetitive activity passed by US Senate committee
Four bills targeting anticompetitive behavior in the pharmaceutical sector were passed out of the US Senate Judiciary Committee, teeing them up for a vote on the Senate floor.Four bills targeting anticompetitive...To view the full article, register now.
Already a subscriber? Click here to view full article